Bray C L, Jain S, Faragher E B, Myers A, Myers P, MacIntyre P, Rae A, Goldman M, Alcorn M
Wythenshawe Hospital, Manchester, U.K.
Eur Heart J. 1991 May;12 Suppl A:16-20.
Suscard is a buccally administered formulation which provides rapid introduction of nitroglycerin directly into the systemic circulation and, by virtue of its sustained-release properties, may confer protection against anginal attacks for several hours. Its efficacy has been established in angina pectoris and more recently its usefulness has been extended to include the management of unstable angina and acute heart failure. Buccal nitroglycerin combines the possibilities of short-term treatment and more extended prophylaxis. In a multicentre double-blind study the efficacy of buccal nitroglycerin and sublingual nitroglycerin were compared in patients with proven chronic stable exercise-induced angina as regards anginal attacks and capacity for physical activity. The conclusion is that the two formulations of nitroglycerin have a comparable effect in the treatment of acute attacks of angina pectoris. Buccal nitroglycerin has many advantages when used prophylactically. This is documented by less frequent anginal attacks and a more prolonged duration of effect resulting in an increased physical activity.
苏斯卡德是一种口腔给药制剂,可将硝酸甘油迅速直接引入体循环,凭借其缓释特性,可在数小时内预防心绞痛发作。其疗效已在心绞痛中得到证实,最近其用途已扩展到包括不稳定型心绞痛和急性心力衰竭的治疗。口腔硝酸甘油兼具短期治疗和长期预防的可能性。在一项多中心双盲研究中,比较了口腔硝酸甘油和舌下硝酸甘油对已证实的慢性稳定运动诱发型心绞痛患者在心绞痛发作和体力活动能力方面的疗效。结论是,两种硝酸甘油制剂在治疗心绞痛急性发作方面具有可比效果。口腔硝酸甘油在预防性使用时有许多优点。这表现为心绞痛发作频率降低,作用持续时间延长,从而体力活动增加。